Food combinations for cholesterol lowering

Nutrition Research Reviews

Volumn 25, Issue 2, 2012, Pages 249-266

  Harland, Janice I ^a  

^a HarlandHall Associates   (United Kingdom)

Author keywords

Glucans; Cholesterol lowering; Food component selection; Soya protein; Stanols; Sterols; Tree nuts

Indexed keywords

BETA GLUCAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SOYBEAN PROTEIN; STANOZOLOL; STEROL;

BEVERAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHEMICAL STRUCTURE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; EXOSKELETON; FAT INTAKE; FIBER; FOOD COMPOSITION; HUMAN; INCIDENCE; LIPID BLOOD LEVEL; MACRONUTRIENT; META ANALYSIS (TOPIC); NUT; NUTRITIONAL HEALTH; NUTRITIONAL REQUIREMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ANTICHOLESTEREMIC AGENTS; BETA-GLUCANS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET; DIETARY FATS; DIETARY FIBER; ENERGY INTAKE; FATTY ACIDS, MONOUNSATURATED; FOOD; FOOD PREFERENCES; HUMANS; HYPERCHOLESTEROLEMIA; MEDLINE; NUTS; PHYTOSTEROLS; SITOSTEROLS; SOLUBILITY; SOYBEAN PROTEINS;

EID: 84870431298     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S0954422412000170     Document Type: Review

References (117)

1. Allender S, Scarborough P, Peto V, et al (2008) European Cardiovascular Disease Statistics http://www.bhf.org.uk/idoc.ashxdocide4f82fee-58f0-4a51-8099- db9520123e24 &version-1 (accessed December 2011).
2. Reiner Z, Catapano AL, De Backer G, et al. (2011) ESC/EAS guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 32, 1769-1818.
3. World Health Organization (2002) The World Health Report 2002; Reducing Risks, Promoting Healthy Life. WHO: Geneva.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486-2497.
5. Joint British Societies (2005) Guidelines on prevention of cardiovascular disease in clinical practice. Heart 91, v1-v52.
6. World Health Organization (2003) Diet, Nutrition and the Prevention of Chronic Diseases. Joint WHO/FAO Expert Consultation. WHO Technical Report Series no. 916. Geneva: WHO.
7. Stanner S (editor) (2005) Cardiovascular Disease: Diet, Nutrition and Emerging Risk Factors (The Report of the British Nutrition Foundation Task Force). Oxford: Blackwell Publishing.
8. Gillingham LG, Harris-Janz S & Jones PJ (2011) Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids 46, 209-228.
9. Ramsden CE, Faurot KR, Carrera-Bastos P, et al. (2009) Dietary fat quality and coronary heart disease prevention: A unified theory based on evolutionary, historical, global, and modern perspectives. Curr Treat Options Cardiovasc Med 11, 289-301.
10. Jenkins DJ, Kendall CW, Axelsen M, et al. (2000) Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease. Curr Opin Lipidol 11, 49-56.
11. Jenkins DJ, Kendall CW, Faulkner D, et al. (2002) A dietary portfolio approach to cholesterol reduction: Combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metabolism 51, 1596-1604.
12. Jenkins DJ, Chiavaroli L, Wong JM, et al. (2010) Adding monounsaturated fatty acids to a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. CMAJ 182, 1961-1967.
13. Miller M, Stone NJ, Ballantyne C, et al. (2011) Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association. Circulation 123, 2292-2333.
14. Abdel-Maksoud M, Sazonov V, Gutkin SW, et al. (2008) Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. J Cardiovasc Pharmacol 51, 331-351.
15. Chapman MJ, Ginsberg HN, Amarenco P, et al. (2011) Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: Evidence and guidance for management. Eur Heart J 32, 1345-1361.
16. Givens DI (2008) Session 4: Challenges facing the food industry in innovating for health. Impact on CVD risk of modifying milk fat to decrease intake of SFA and increase intake of cis-MUFA. Proc Nutr Soc 67, 419-427.
17. Keys A (1965) Effects of different dietary fats on plasmalipid levels. Lancet i, 318-319.
18. Mensink RP, Zock PL, Kester AD, et al. (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-Analysis of 60 controlled trials. Am J Clin Nutr 77, 1146-1155.
19. Minihane AM & Harland JI (2007) Changing the fat composition of the diet by using improved frying oils. In Nutrition and Health: Current Topics 6-7, pp. 51-57 [T Haffner, editor]. Hertford: Complete Media and Marketing Ltd.
20. Harland JI (2009) An assessment of the economic and heart health benefits of replacing saturated fat in the diet with monounsaturates in the form of canola (rapeseed) oil. Nutr Bull 34, 174-184.
21. Keys A, Menotti A, Karvonen MJ, et al. (1986) The diet and 15-year death rate in the Seven Countries Study. Am J Epidemiol 124, 903-915.
22. Hu FB, Stampfer MJ, Manson JE, et al. (1997) Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337, 1491-1499.
23. Swain JF, McCarron PB, Hamilton EF, et al. (2008) Characteristics of the diet patterns tested in the Optimal Macronutrient Intake Trial to Prevent Heart Disease (Omni-Heart): Options for a heart-healthy diet. J Am Diet Assoc 108, 257-265.
24. Vessby B, Unsitupa M, Hermansen K, et al. (2001) Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 44, 312-319.
25. Department of Health (1994) Committee of Medical Aspects of Food Policy (COMA): Nutritional Aspects of Cardiovascular Disease. London: H.M. Stationery Office.
26. SimopoulosAP(2008)Theimportanceof theomega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 233, 674-688.
27. European Food Safety Authority (2009) Scientific opinion: Plant stanols and plant sterols and blood LDL-cholesterol. Scientific opinion of the Panel on Dietetic Products, Nutrition and Allergies on a request from the European Commission and a similar request from France in relation to the authorization procedure for health claims on plant stanols and plant sterols and lowering/reducing blood LDL-cholesterol pursuant to Article 14 of Regulation (EC) no 1924/2006. Opinion of the Panel on Dietetic Products, Nutrition and Allergies. EFSA J 1175, 1-9.
28. Food and Drug Administration (2000) Food labeling: Health claims; plant sterol/stanol esters and coronary heart disease; interim final rule http://www.fda.gov/Food/LabelingNutrition/LabelClaims/ HealthClaimsMeetingSignificantScientificAgreementSSA/ucm074747.htm (accessed August 2012).
29. Katan MB, Grundy SM, Jones P, et al. (2003) Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 78, 965-978.
30. Law M (2000) Plant sterol and stanol margarines and health. BMJ 320, 861-864.
31. Demonty I, Ras RT, van der Knaap HC, et al. (2009) Continuous dose-response relationship of the LDL-cholesterollowering effect of phytosterol intake. J Nutr 139, 271-284.
32. Abumweis SS, Barake R & Jones PJ (2008) Plant sterols/stanols as cholesterol lowering agents: A meta-Analysis of randomized controlled trials Food Nutr Res 52 (epublication 18 August 2008).
33. Wu T, Fu J, Yang Y, et al. (2009) The effects of phytosterols/stanols on blood lipid profiles: A systematic review with meta-Analysis. Asia Pac J Clin Nutr 18, 179-186.
34. Musa-Veloso K, Poon TH, Elliot JA, et al. (2011) A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: Results of a meta-Analysis of randomized, placebo-controlled trials. Prostaglandins Leukot Essent Fatty Acids 85, 9-28.
35. Talati R, Sobieraj DM, Makanji SS, et al. (2010) The comparative efficacy of plant sterols and stanols on serum lipids: A systematic review and meta-Analysis. J Am Diet Assoc 110, 719-726.
36. Anderson JW, Johnstone BM & Cook-Newell ME (1995) Meta-Analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333, 276-282.
37. Reynolds K, Chin A, Lees KA, et al. (2006) A meta-Analysis of the effect of soy protein supplementation on serum lipids. Am J Cardiol 98, 633-640.
38. Weggemans RM & Trautwein EA (2003) Relation between soy-Associated isoflavones and LDL and HDL cholesterol concentrations in humans: A meta-Analysis. Eur J Clin Nutr 57, 940-946.
39. Zhuo XG, Melby MK & Watanabe S (2004) Soy isoflavone intake lowers serum LDL cholesterol: A meta-Analysis of 8 randomized controlled trials in humans. J Nutr 134, 2395-2400.
40. Balk E, Chung M, Chew P, et al (2005) Effect of soy on health outcomes. In Evidence Report/Technology Assessment no. 126, pp. 1-94. Rockville, MD: Agency for Healthcare Research and Quality.
41. Zhan S & Ho SC (2005) Meta-Analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81, 397-408.
42. Taku K, Umegaki K, Sato Y, et al. (2007) Soy isoflavones lower serum total and LDL cholesterol in humans: A metaanalysis of 11 randomized controlled trials. Am J Clin Nutr 85, 1148-1156.
43. Harland JI & Haffner TA (2008) Systematic review, metaanalysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol. Atherosclerosis 200, 13-27.
44. Hooper L, Kroon PA, Rimm EB, et al. (2008) Flavonoids, flavonoid-rich foods, and cardiovascular risk: A meta-Analysis of randomized controlled trials. Am J Clin Nutr 88, 38-50.
45. Jenkins DJ, Mirrahimi A, Srichaikul K, et al. (2010) Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr 140, 2302S-2311S.
46. Anderson JW & Bush HM (2011) Soy protein effects on serum lipoproteins: A quality assessment and meta-Analysis of randomized, controlled studies. J Am Coll Nutr 30, 79-91.
47. Sirtori CR, Eberini I & Arnoldi A (2007) Hypocholesterolaemic effects of soya proteins: Results of recent studies are predictable from the Anderson meta-Analysis data. Br J Nutr 97, 816-822.
48. Jenkins DJA, Mirrahimi A, Srichaikul K, et al. (2010) Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr 140, 2302S-2311S.
49. Gardner CD, Messina M, Kiazand A, et al. (2007) Effect of two types of soy milk and dairy milk on plasma lipids in hypercholesterolemic adults: A randomized trial. J Am Coll Nutr 26, 669-677.
50. Joint Health Claims Initiative (2002) Generic health claim for soya protein and blood cholesterol. www.jhci.org.uk (accessed December 2011).
51. Anonymous (1999) Food labeling: Health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule. Fed Regist 64, 57700-57733.
52. Brown L, Rosner B, Willett WW, et al. (1999) Cholesterollowering effects of dietary fiber: A meta-Analysis. Am J Clin Nutr 69, 30-42.
53. Ripsin CM, Keenan JM, Jacobs DR Jr, et al. (1992) Oat products and lipid lowering. A meta-Analysis. JAMA 267, 3317-3325.
54. EFSA Panel on Dietetic Products; Nutrition and Allergies (NDA) (2010) Scientific opinion on the substantiation of a health claim related to oat b-glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) no 1924/2006 EFSA J 8, 1885.
55. Talati R, Baker WL, Pabilonia MS, et al. (2009) The effects of barley-derived soluble fiber on serum lipids. Ann Fam Med 7, 157-163.
56. Abumweis SS, Jew S & Ames NP (2010) b-Glucan from barley and its lipid-lowering capacity: A meta-Analysis of randomized, controlled trials. Eur J Clin Nutr 64, 1472-1480.
57. Ariyo AA & Villablanca AC (2002) Estrogens and lipids Can HRT designer estrogens, and phytoestrogens reduce cardiovascular risk markers after menopause Postgrad Med 111, 23-30.
58. EFSA (2009) Scientific opinion on the substantiation of health claims related to b-glucans and maintenance of normal blood cholesterol concentrations (ID 754, 755, 757, 801, 1465, 2934) and maintenance or achievement of a normal body weight (ID 820, 823) pursuant to Article 13(1) of Regulation (EC) no 1924/20061. EFSA J 7, 1254.
59. EFSA Panel on Dietetic Products; Nutrition and Allergies (NDA) (2011) Scientific opinion on the substantiation of a health claim related to barley b-glucans and lowering of blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) no 1924/20061. EFSA Journal 9, 2470.
60. Seal CJ (2006) Whole grains and CVD risk. Proc Nutr Soc 65, 24-34.
61. Mellen PB, Walsh TF & Herrington DM (2008) Whole grain intake and cardiovascular disease: A meta-Analysis. Nutr Metab Cardiovasc Dis 18, 283-290.
62. EFSA Panel on Dietetic Products; Nutrition and Allergies (NDA) (2010) Scientific opinion on the substantiation of health claims related to pectins and reduction of post-prandial glycaemic responses (ID 786), maintenance of normal blood cholesterol concentrations (ID 818) and increase in satiety leading to a reduction in energy intake (ID 4692) pursuant to Article 13(1) of Regulation (EC) no 1924/2006. EFSA J 8, 1747.
63. EFSA Panel on Dietetic Products; Nutrition and Allergies (NDA) (2011) Scientific opinion on the substantiation of health claims related to chitosan and reduction in body weight (ID 679, 1499), maintenance of normal blood LDLcholesterol concentrations (ID4663), reduction of intestinal transit time (ID 4664) and reduction of inflammation (ID1985) pursuant to Article 13(1) of Regulation (EC) no 1924/2006. EFSA J 9, 2214.
64. Kris-Etherton PM, Hu FB, Ros E, et al. (2008) The role of tree nuts and peanuts in the prevention of coronary heart disease: Multiple potential mechanisms. J Nutr 138, 1746S-1751S.
65. Mukuddem-Petersen J, Oosthuizen W & Jerling JCA (2005) systematic review of the effects of nuts on blood lipid profiles in humans. J Nutr 135, 2082-2089.
66. Phung OJ, Makanji SS, White CM, et al. (2009) Almonds have a neutral effect on serum lipid profiles: A meta-Analysis of randomized trials. J Am Diet Assoc 109, 865-873.
67. Banel DK & Hu FB (2009) Effects of walnut consumption on blood lipids and other cardiovascular risk factors: A meta-Analysis and systematic review. Am J Clin Nutr 90, 56-63.
68. Damasceno NRT, Pérez-Heras A, Serra M, et al. (2011) Crossover study of diets enriched with virgin olive oil, walnuts or almonds. Effects on lipids and other cardiovascular risk markers. Nutr Metab Cardiovasc Dis 21, Suppl. 1, S14-S20.
69. King JC, Blumberg J, Ingwersen L, et al. (2008) Tree nuts and peanuts as components of a healthy diet. J Nutr 138, 1736S-1740S.
70. EFSA Panel on Dietetic Products; Nutrition and Allergies (NDA) (2010) Scientific opinion on the substantiation of health claims related to Camellia sinensis (L.) kuntze (tea), including catechins in green tea and tannins in black tea, and protection of DNA, proteins and lipids from oxidative damage (ID 1103, 1276, 1311, 1708, 2664), reduction of acid production in dental plaque (ID 1105, 1111), maintenance of bone (ID 1109), decreasing potentially pathogenic intestinal microorganisms (ID 1116), maintenance of vision (ID 1280), maintenance of normal blood pressure (ID 1546) and maintenance of normal blood cholesterol concentrations (ID 1113, 1114) pursuant to Article 13(1) of Regulation (EC) no 1924/2006. EFSA J 8, 1463.
71. Zhang W, Wang X, Liu Y, et al. (2008) Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. Br J Nutr 99, 1301-1309.
72. Pan A, Yu D, Demark-Wahnefried W, et al. (2009) Metaanalysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr 90, 288-297.
73. EFSA Panel on Dietetic Products; Nutrition and Allergies (NDA) (2009) Scientific opinion on the substantiation of health claims related to a-linolenic acid and maintenance of normal blood cholesterol concentrations (ID 493) and maintenance of normal blood pressure (ID 625) pursuant to Article 13(1) of Regulation (EC) no 1924/2006 on request from the European Commission. EFSA J 7, 1252.
74. Bazzano LA, Thompson AM, Tees MT, et al. (2011) Non-soy legume consumption lowers cholesterol levels: A metaanalysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 21, 94-103.
75. Khoo YS & Aziz Z (2009) Garlic supplementation and serum cholesterol: A meta-Analysis. J Clin Pharm Ther 34, 133-145.
76. Rana SV, Pal R, Vaiphe K, et al. (2011) Garlic in health and disease. Nutr Res Rev 24, 60-71.
77. Jenkins DJ, Kendall CW, Marchie A, et al. (2005) Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr 81, 380-387.
78. Jenkins DJ, Jones PJ, Lamarche B, et al. (2011) Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: A randomized controlled trial. JAMA 306, 831-839.
79. Jenkins DJ, Wong JM, Kendall CW, et al. (2009) The effect of a plant-based low-carbohydrate ("Eco-Atkins") diet on body weight and blood lipid concentrations in hyperlipidemic subjects. Arch Intern Med 169, 1046-1054.
80. Jenkins DJ, Kendall CW, Nguyen TH, et al. (2008) Effect of plant sterols in combination with other cholesterol-lowering foods. Metabolism 57, 130-139.
81. Jenkins DJ, Kendall CW, Faulkner DA, et al. (2006) Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. Am J Clin Nutr 83, 582-591.
82. Lamarche B, Desroches S, Jenkins DJ, et al. (2004) Combined effects of a dietary portfolio of plant sterols, vegetable protein, viscous fibre and almonds on LDL particle size. Br J Nutr 92, 657-663.
83. Jenkins DJ, Kendall CW, Marchie A, et al. (2003) Effects of a dietary portfolio of cholesterol-lowering foods vs. lovastatin on serum lipids and C-reactive protein. JAMA 290, 502-510.
84. Jenkins DJ, Kendall CW, Marchie A, et al. (2003) The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia. Metabolism 52, 1478-1483.
85. Jenkins DJ, Kendall CW, Mehling CC, et al. (1999) Combined effect of vegetable protein (soy) and soluble fiber added to a standard cholesterol-lowering diet. Metabolism 48, 809-816.
86. Robinson JG & Maheshwari N (2005) A "poly-portfolio" for secondary prevention: A strategy to reduce subsequent events by up to 97% over five years. Am J Cardiol 95, 373-378.
87. Jenkins DJ, Kendall CW, Faulkner DA, et al. (2008) Longterm effects of a plant-based dietary portfolio of cholesterol-lowering foods on blood pressure. Eur J Clin Nutr 62, 781-788.
88. Jenkins DJ, Kendall CW, Nguyen TH, et al. (2007) Effect on hematologic risk factors for coronary heart disease of a cholesterol reducing diet. Eur J Clin Nutr 61, 483-492.
89. Gigleux I, Jenkins DJ, Kendall CW, et al. (2007) Comparison of a dietary portfolio diet of cholesterol-lowering foods and a statin on LDL particle size phenotype in hypercholesterolaemic participants. Br J Nutr 98, 1229-1236.
90. Jones PJ, Raeini-Sarjaz M, Jenkins DJ, et al. (2005) Effects of a diet high in plant sterols, vegetable proteins, and viscous fibers (dietary portfolio) on circulating sterol levels and red cell fragility in hypercholesterolemic subjects. Lipids 40, 169-174.
91. Jenkins DJ, Kendall CW, Marchie A, et al. (2005) Direct comparison of dietary portfolio vs statin on C-reactive protein. Eur J Clin Nutr 59, 851-860.
92. Jenkins DJ, Nguyen TH, Kendall CW, et al. (2008) The effect of strawberries in a cholesterol-lowering dietary portfolio. Metabolism 57, 1636-1644.
93. Minihane AM & Harland JI (2007) Impact of oil used by the frying industry on population fat intake. Crit Rev Food Sci Nutr 47, 287-297.
94. Deng R (2009) Food and food supplements with hypocholesterolemic effects. Recent Pat Food Nutr Agric 1, 15-24.
95. Brown AW, Hang J, Dussault PH, et al. (2010) Phytosterol ester constituents affect micellar cholesterol solubility in model bile. Lipids 45, 855-862.
96. Vuksan V, Jenkins AL, Rogovik AL, et al. (2011) Viscosity rather than quantity of dietary fibre predicts cholesterollowering effect in healthy individuals. Br J Nutr 106, 1349-1352.
97. Theuwissen E & Mensink RP (2008) Water-soluble dietary fibers and cardiovascular disease. Physiol Behav 94, 285-292.
98. Brouns F, Theuwissen E, Adam A, et al. (2012) Cholesterollowering properties of different pectin types in mildly hyper-cholesterolemic men and women. Eur J Clin Nutr 66, 591-599.
99. Manzoni C, Duranti M, Eberini I, et al. (2003) Subcellular localization of soybean 7S globulin in HEPg2 cells and LDL receptor up-regulation by its alpha0 constituent subunit. J Nutr 133, 2149-2155.
100. Xiao CW, Mei J & Wood CM (2008) Effect of soy proteins and isoflavones on lipid metabolism and involved gene expression. Front Biosci 13, 2660-2673.
101. Taku K, Umegaki K, Ishimi Y, et al. (2008) Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Meta-Analysis of randomized controlled trials. Ther Clin Risk Manag 4, 1097-1103.
102. EFSA Panel on Dietetic Products: Nutrition and Allergies (NDA) (2011) Scientific opinion on the substantiation of health claims related to walnuts and maintenance of normal blood LDL-cholesterol concentrations (ID 1156, 1158) and improvement of endothelium-dependent vasodilation (ID 1155, 1157) pursuant to Article 13(1) of Regulation (EC) no 1924/2006. EFSA J 9, 2074.
103. Theuwissen E & Mensink RP (2007) Simultaneous intake of b-glucan and plant stanol esters affects lipid metabolism in slightly hypercholesterolemic subjects. J Nutr 137, 583-588.
104. De Looy AE, Auty PL & Coates CA (1992) Is our dietary advice effective Proc Nutr Soc 51, 63-69.
105. Fehily AM, Vaughan-Williams E, Shiels K, et al. (1991) Factors influencing compliance with dietary advice: The Diet and Reinfarction Trial (DART). J Hum Nutr Diet 4, 33-42.
106. Appel LJ, Sacks FM, Carey VJ, et al. (2005) Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: Results of the OmniHeart randomized trial. JAMA 294, 2455-2464.
107. Yoshida M, Vanstone CA, Parsons WD, et al. (2006) Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes. Eur J Clin Nutr 60, 529-537.
108. Van Horn L, Liu K, Gerber J, et al. (2001) Oats and soy in lipid-lowering diets for women with hypercholesterolemia: Is there synergy J Am Diet Assoc 101, 1319-1325.
109. Weidner C, Krempf M, Bard JM, et al. (2008) Cholesterol lowering effect of a soy drink enriched with plant sterols in a French population with moderate hypercholesterolemia. Lipids Health Dis 7, 35.
110. Cicero AF, Minardi M, Mirembe S, et al. (2004) Effects of a new low dose soy protein/b-sitosterol association on plasma lipid levels and oxidation. Eur J Nutr 43, 319-322.
111. Cicero AF, Fiorito A, Panourgia MP, et al. (2002) Effects of a new soy/b-sitosterol supplement on plasma lipids in moderately hypercholesterolemic subjects. J Am Diet Assoc 102, 1807-1811.
112. Shrestha S, Volek JS, Udani J, et al. (2006) A combination therapy including psyllium and plant sterols lowers LDL cholesterol by modifying lipoprotein metabolism in hypercholesterolemic individuals. J Nutr 136, 2492-2497.
113. Theuwissen E, Plat J & Mensink RP (2009) Consumption of oat b-glucan with or without plant stanols did not influence inflammatory markers in hypercholesterolemic subjects. Mol Nutr Food Res 53, 370-376.
114. Lukaczer D, Liska DJ, Lerman RH, et al. (2006) Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women. Nutrition 22, 104-113.
115. Torres N, Guevara-Cruz M, Granados J, et al. (2009) Reduction of serum lipids by soy protein and soluble fiber is not associated with the ABCG5/G8, apolipoprotein E, and apolipoprotein A1 polymorphisms in a group of hyperlipidemic Mexican subjects. Nutr Res 29, 728-735.
116. Baigent C, Blackwell L, Emberson J, et al. (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-Analysis of data from 170,000 participants in 26 randomised trials. Lancet 376, 1670-1681.
117. Holland B, Welch AA and Buss DH, et al (editors) (1997) In McCance and Widdowson's The Composition of Foods, Fifth Revised and Extended Edition. London: The Royal Society of Chemistry and Ministry of Agriculture, Fisheries and Food.